Minicourse on homeostatic achievements about hormones and blood pressure: a challenge for chronobiologic engineering and computing
暂无分享,去创建一个
L. Martini | Franz Halberg | O. Carandente | F. Carandente | F. Halberg | F. Carandente | L. Martini | O. Carandente
[1] F. Halberg,et al. Differences and similarities among circadian characteristics of plasma renin activity in healthy young women in Japan and the United States. , 1980, The American journal of medicine.
[2] R. Dluhy,et al. DOPAMINERGIC BLOCKADE OF THE RENIN‐ANGIOTENSIN‐ALDOSTERONE SYSTEM: EFFECT OF HIGH AND LOW SODIUM INTAKES , 1983, Clinical endocrinology.
[3] J. Ménard,et al. Direct radioimmunoassay of human renin. , 1979, The Journal of clinical endocrinology and metabolism.
[4] P. Weidmann,et al. Plasma levels and cardiovascular, endocrine, and excretory effects of atrial natriuretic peptide during different sodium intakes in man. , 1986, The Journal of clinical endocrinology and metabolism.
[5] G. Cornelissen,et al. Important time, though not causal, relations in atrial natriuretic peptide, cortisol and renin. , 1986, Chronobiologia.
[6] J. Seidman,et al. Atrial natriuretic peptide transcription, secretion, and glomerular receptor activity during mineralocorticoid escape in the rat. , 1986, The Journal of clinical investigation.
[7] J. Sowers,et al. Effect of metoclopramide and domperidone on aldosterone, 18-hydroxycorticosterone and prolactin secretion in the rhesus monkey. , 1982, Metabolism: clinical and experimental.
[8] C. Gomez-Sanchez. Cushing's syndrome and hypertension. , 1986, Hypertension.
[9] N. Trippodo,et al. Natriuretic response to atrial natriuretic factor enhanced by angiotensin II and vasopressin. , 1984, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[10] E. Baulieu. Current Approaches to Steroid Hormone-Cell Interactions , 1979 .
[11] G. Cornelissen,et al. Circadian rhythms of plasma renin activity and aldosterone: changes related to age, sex, recumbency and sodium restriction. Chronobiologic specification for reference values. , 1985, Chronobiology international.
[12] L. Navar,et al. Effects of Angiotensin on the Renal Circulation , 1974 .
[13] J. Oates,et al. Malignant Hypertension: Effect of Therapy on Renin and Aldosterone , 1971, Circulation research.
[14] M. Cantin,et al. Mechanisms of release of atrial natriuretic factor. I. Effect of several agonists and steroids on its release by atrial minces. , 1986, Biochemical and biophysical research communications.
[15] P. Needleman,et al. Vasopressin-stimulated release of atriopeptin: endocrine antagonists in fluid homeostasis. , 1985, Science.
[16] G. Cornelissen,et al. Effect of ageing on circadian rhythms of plasma renin and aldosterone in mesor-hypertensive women. , 1982, Maturitas.
[17] S. Snyder,et al. Angiotensin-converting enzyme in the testis and epididymis: differential development and pituitary regulation of isozymes. , 1985, Endocrinology.
[18] J. Laragh,et al. Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis. , 1985, The New England journal of medicine.
[19] G. Norbiato,et al. Metoclopramide increases plasma aldosterone concentration in man. , 1977, The Journal of clinical endocrinology and metabolism.
[20] S. Bloom,et al. The plasma atrial natriuretic peptide response to treatment of acute cardiac failure, spontaneous supraventricular tachycardia and induced re-entrant tachycardia in man. , 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[21] R. Luke,et al. Reduction of toxicity of corticosteroid therapy after renal transplantation. , 1972, The American journal of medicine.
[22] T. Strom,et al. Comparison of Plasma Atrial Natriuretic Peptide Levels in Healthy Children from Birth to Adolescence and in Children with Cardiac Diseases1 , 1986, Pediatric Research.
[23] R. Carey,et al. Dopamine inhibits the aldosterone response to upright posture. , 1986, The Journal of clinical endocrinology and metabolism.
[24] C. Edwards,et al. IN VIVO AND IN VITRO STUDIES ON THE EFFECT OF METOCLOPRAMIDE ON ALDOSTERONE SECRETION , 1980, Clinical endocrinology.
[25] C. Johnston,et al. LONG-TERM EFFECTS OF CAPTOPRIL (SQ14 225) ON BLOOD-PRESSURE AND HORMONE LEVELS IN ESSENTIAL HYPERTENSION , 1979, The Lancet.
[26] R. Cuneo,et al. Studies on the secretion, metabolism and action of atrial natriuretic peptide in man. , 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[27] R. Dluhy,et al. β-Endorphin Stimulates Plasma Renin and Aldosterone Release in Normal Human Subjects* , 1985 .
[28] E. Silverstein,et al. Elevated serum angiotensin-converting enzyme in hyperthyroidism. , 1983, The American journal of medicine.
[29] G. Cornelissen,et al. Construction of rhythm-specified reference intervals and regions, with emphasis on 'hybrid' data, illustrated for plasma cortisol. , 1983, Chronobiologia.
[30] K. Kangawa,et al. Structural identification of β- and γ-human atrial natriuretic polypeptides , 1985, Nature.
[31] H. Sekihara,et al. Plasma levels of atrial natriuretic peptide in primary aldosteronism and essential hypertension. , 1986, The Journal of clinical endocrinology and metabolism.
[32] H. L. Stone,et al. The effect of metoclopramide and dopamine on plasma aldosterone concentration in normal man and rhesus monkeys (Macaca mulatta): a new model to study dopamine control of aldosterone secretion. , 1982, The Journal of clinical endocrinology and metabolism.
[33] R. Fraser,et al. DOPAMINE EFFECTS ON 11‐DEOXYCORTICOSTERONE CONCENTRATIONS IN PATIENTS WITH CUSHING'S SYNDROME AND IN VITRO , 1986, Clinical endocrinology.
[34] E. H. Blaine,et al. Synthetic Atrial Natriuretic Factor in Conscious Normotensive and Hypertensive Rats , 1985, Hypertension.
[35] S. Ball,et al. Diurnal change in plasma atrial natriuretic peptide concentrations. , 1987, Clinical science.
[36] W. Samson,et al. Atrial Natriuretic Factor Inhibits Vasotocin-Induced Water Reabsorption in the Toad Urinary Bladder , 1986, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[37] J. Laragh,et al. Cardiovascular effects of atrial natriuretic factor in anesthetized and conscious dogs. , 1986, Hypertension.
[38] E. Slater,et al. Pure human renin. Identification and characterization and of two major molecular weight forms. , 1981, The Journal of biological chemistry.
[39] T. Flynn,et al. The amino acid sequence of an atrial peptide with potent diuretic and natriuretic properties. , 1983, Biochemical and biophysical research communications.
[40] T. Eisenhauer,et al. Detection of fluid overload by plasma concentration of human atrial natriuretic peptide (h-ANP) in patients with renal failure. , 1986, Klinische Wochenschrift.
[41] J. Melby,et al. Converting-enzyme inhibitor administration lowers urinary free 19-nor-deoxycorticosterone levels. , 1985, Hypertension.
[42] J. Bauer,et al. Hemodynamic and renal function in essential hypertension during treatment with enalapril. , 1985, The American journal of medicine.
[43] E. Espiner,et al. Lack of direct effect of dopamine on aldosterone secretion in vivo. , 1983, Endocrinology.
[44] P. Erne,et al. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. , 1986, The New England journal of medicine.
[45] P. Needleman,et al. Ser-Leu-Arg-Arg-atriopeptin III: the major circulating form of atrial peptide. , 1985, Science.
[46] A. Ahlgren,et al. Circadian systolic and diastolic hyperbaric indices of high school and college students. , 1984, Chronobiologia.
[47] R. Nutt,et al. Vasodilator profile of synthetic atrial natriuretic factor. , 1984, European journal of pharmacology.
[48] M. Cantin,et al. Distinct localization of atrial natriuretic factor and angiotensin II binding sites in the glomerulus. , 1986, The American journal of physiology.
[49] Andrew,et al. Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. , 1986, The Journal of clinical investigation.
[50] W. Ganong,et al. Extra-atrial expression of the gene for atrial natriuretic factor. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[51] F. Beck,et al. Absent aldosterone response to metoclopramide in patients with high spinal cord transection: evidence that metoclopramide stimulates aldosterone secretion through central pathways. , 1985, Life sciences.
[52] M. Sambhi,et al. Effect of L-dopa and bilateral nephrectomy on the aldosterone response to metoclopramide. , 1980, Life sciences.
[53] N. Shock,et al. Association between blood pressure and the rate of decline in renal function with age. , 1984, Kidney international.
[54] A. Shore,et al. EFFECTS OF CHANGES IN DIETARY SODIUM INTAKE AND SALINE INFUSION ON IMMUNOREACTIVE ATRIAL NATRIURETIC PEPTIDE IN HUMAN PLASMA , 1985, The Lancet.
[55] G. Cornélissen,et al. Chronobiologic blood pressure assessment with a cardiovascular summary, the sphygmochron , 1990 .
[56] L. Resnick,et al. Angiotensin I converting enzyme activity in hypertension. Relationship to blood pressure, renin-sodium profiles, and antihypertensive therapy. , 1985, The American journal of medicine.
[57] S. Bloom,et al. Diurnal rhythm in the plasma concentration of atrial natriuretic peptide. , 1986, The New England journal of medicine.
[58] R. Carey,et al. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone. , 1979, The Journal of clinical investigation.
[59] E. Bates,et al. The relationship between plasma levels of immunoreactive atrial natriuretic hormone and hemodynamic function in man. , 1986, Circulation.
[60] D. Ganten,et al. Plasma atrial natriuretic peptide values in cardiac disease. , 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[61] G. Cornelissen,et al. Effect of an adrenocorticotropin analogue, ACTH 1-17, on DNA synthesis in murine metaphyseal bone. , 1985, Biochemical pharmacology.
[62] K. Catt,et al. Dopaminergic modulation of aldosterone secretion in the rat. , 1984, Endocrinology.
[63] R. Carey,et al. Possible mechanism of action of metoclopramide-induced aldosterone secretion: in vivo and in vitro studies in the sheep. , 1983, Endocrinology.
[64] J. Funder,et al. The etiology of a syndrome of factitious mineralocorticoid excess: a steroid-containing nasal spray. , 1979, The Journal of clinical endocrinology and metabolism.
[65] F. Beck,et al. Dopaminergic regulation of 18-hydroxycorticosterone and aldosterone secretion in man. , 1983, Acta endocrinologica.
[66] B. McEwen,et al. Adrenal steroid receptors and actions in the nervous system. , 1986, Physiological reviews.
[67] F. Takaku,et al. Atrial natriuretic factor in human blood. , 1985, The Journal of clinical investigation.
[68] R. Dluhy,et al. Dopaminergic modulation of aldosterone responsiveness to angiotensin II with changes in sodium intake. , 1983, The Journal of clinical endocrinology and metabolism.
[69] D. Schrier,et al. Inhibition of vascular permeability changes in rats by captopril. , 1982, The Journal of clinical investigation.
[70] M. Littner,et al. Circadian rhythm of plasma renin activity in older normal and essential hypertensive men: relation with inactive renin, aldosterone, cortisol and REM sleep. , 1986, Journal of hypertension.
[71] J. O. Davis,et al. Mechanisms regulating renin release. , 1976, Physiological reviews.
[72] C. Saper,et al. Atriopeptins as cardiac hormones. , 1985, Hypertension.
[73] J. Ménard,et al. Multiple forms of human renin. Purification and characterization. , 1979, The Journal of biological chemistry.
[74] E. Schiffrin,et al. Vascular and Adrenal Binding Sites for Atrial Natriuretic Factor Effects of Sodium and Hypertension , 1986 .
[75] J. Sowers,et al. Dopaminergic regulation of circadian rhythms of blood pressure, renin and aldosterone in essential hypertension. , 1982, Cardiovascular research.
[76] M. Yasujima,et al. Effects of acute water load, hypertonic saline infusion, and furosemide administration on atrial natriuretic peptide and vasopressin release in humans. , 1986, The Journal of clinical endocrinology and metabolism.
[77] M. Epstein,et al. Increases in circulating atrial natriuretic factor during immersion-induced central hypervolaemia in normal humans. , 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[78] H. Gavras,et al. Reciprocal relation between renin dependency and sodium dependency in essential hypertension. , 1976, The New England journal of medicine.
[79] H. Yokosawa,et al. Human renal renin. Complete purification and characterization. , 1980, The Journal of biological chemistry.
[80] A. Gerbes,et al. Atrial natriuretic factor in plasma of patients with arterial hypertension, heart failure or cirrhosis of the liver. , 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[81] J. Sowers,et al. Circadian blood pressure and renin, aldosterone, cortisol, and prolactin levels in hypertensive pseudohypoparathyroid patients. , 1982, The Journal of clinical endocrinology and metabolism.
[82] E. Schiffrin,et al. Cyclic GMP as mediator and biological marker of atrial natriuretic factor. , 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[83] F. Halberg. Quo vadis basic and clinical chronobiology: promise for health maintenance. , 1983, The American journal of anatomy.
[84] B. Brenner,et al. Biologically active atrial peptides. , 1985, The Journal of clinical investigation.
[85] S. Tretli,et al. ENALAPRIL, ATENOLOL, AND HYDROCHLOROTHIAZIDE IN MILD TO MODERATE HYPERTENSION A Comparative Multicentre Study in General Practice in Norway , 1986, The Lancet.
[86] R. Horton,et al. Role of atrial natriuretic factor in renin release. , 1986, Endocrinology.
[87] J. Tait,et al. The effect of serotonin and potassium on corticosterone and aldosterone production by isolated zona glomerulosa cells of the rat adrenal cortex. , 1972, Australian Journal of Experimental Biology and Medical Science.
[88] J. Hampton,et al. Treatment of high blood pressure: should clinical practice be based on results of clinical trials? , 1986, British medical journal.
[89] G. Cornelissen,et al. Circadian rhythms of plasma renin, aldosterone and cortisol on habitual and low dietary sodium intake. , 1981, Hormone research.
[90] T. Tulassay,et al. ATRIAL NATRIURETIC PEPTIDE IN PLASMA OF VOLUME-OVERLOADED CHILDREN WITH CHRONIC RENAL FAILURE , 1985, The Lancet.
[91] E. Biglieri,et al. 17-hydroxylation deficiency in man. , 1966, The Journal of clinical investigation.
[92] A. D. de Bold,et al. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. , 1981, Life sciences.
[93] G. Lenoir,et al. Nyctohemeral Rhythm of Plasma Renin Activity and Plasma Aldosterone in Children , 1982, Pediatric Research.
[94] R. Gerzer,et al. The increase of cGMP by atrial natriuretic factor correlates with the distribution of particulate guanylate cyclase , 1985, FEBS letters.
[95] H. Imura,et al. Significance of α‐Human Atrial Natriuretic Polypeptide as a Hormone in Humans , 1986 .
[96] D. Wilson,et al. Atrial natriuretic factor inhibits sodium transport in medullary collecting duct. , 1986, The American journal of physiology.
[97] D. Lykken,et al. Rhythmometry reveals heritability of circadian characteristics of heart rate of human twins reared apart. , 1984, Cardiologia.
[98] G. Nyberg,et al. Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. , 1986, British medical journal.
[99] R. Nutt,et al. Specific membrane receptors for atrial natriuretic factor in renal and vascular tissues. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[100] J. Pfeilschifter,et al. Atrial natriuretic peptide inhibits renin release from juxtaglomerular cells by a cGMP-mediated process. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[101] P. Weidmann,et al. Effects of posture and ageing on circulating atrial natriuretic peptide levels in man. , 1987, Journal of hypertension.
[102] J. Biollaz,et al. Four‐Hour Infusions of Synthetic Atrial Natriuretic Peptide in Normal Volunteers , 1986, Hypertension.
[103] Y. Kawano,et al. The renin-angiotensin-aldosterone system and circadian rhythm of urine variables in normotensive and hypertensive subjects. , 1984, Japanese circulation journal.
[104] S. Bloom,et al. Atrial natriuretic peptide: physiological release associated with natriuresis during water immersion in man. , 1986, Clinical science.
[105] R. Kageyama,et al. Cloning and sequence analysis of cDNA for rat angiotensinogen. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[106] A. Shulkes,et al. Effect of intravenous infusion of corticosteroids on blood pressure, electrolytes, and water metabolism in sheep. , 1975, The American journal of physiology.
[107] J. Melby,et al. Adrenocortical Factors in Hypertension , 1985, Journal of clinical pharmacology.
[108] R. Carey,et al. Control of renal function by intrarenal angiotensin II. , 1983, Endocrinology.
[109] [Circadian rhythm of plasma renin activity]. , 1979, Minerva cardioangiologica.
[110] J. Boger,et al. Comparison of Renin and Converting Enzyme Inhibition in Sodium‐Deficient Dogs , 1985, Hypertension.
[111] G. Vinson,et al. Dopaminergic control of aldosterone: Modulation of the response of rat adrenal zona glomerulosa cells to α-MSH by pretreatment with bromocriptine or metoclopramide , 1982, Steroids.
[112] R. Gordon,et al. PLASMA LEVELS OF ATRIAL NATRIURETIC PEPTIDE IN MAN IN PRIMARY ALDOSTERONISM, IN GORDON'S SYNDROME AND IN BARTTER'S SYNDROME , 1986, Clinical and experimental pharmacology & physiology.
[113] W. Roberts,et al. The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy: A study of 36 necropsy patients , 1975 .
[114] F. Halberg,et al. 24-Hour Rhythms at Several Levels of Integration in Mice on Different Lighting Regimens.∗ , 1958, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[115] A. Bongiovanni,et al. Plasma and urinary corticosteroids in the hypertensive form of congenital adrenal hyperplasia. , 1956, The Journal of biological chemistry.
[116] R. Sothern,et al. Ageing and circadian rhythm of plasma renin and aldosterone. , 1981, Maturitas.
[117] F. Halberg,et al. Comparison of circadian rhythms of the renin-angiotensin-aldosterone system and electrolytes in clinically healthy young women in Fukuoka (Japan) and Minnesota (USA). , 1983, Acta endocrinologica.
[118] P. Weidmann,et al. Blood levels and renal effects of atrial natriuretic peptide in normal man. , 1986, The Journal of clinical investigation.
[119] J. Agarwal,et al. Blood Flow and Tissue Space of the Left Coronary Artery in Man , 1970, Circulation research.
[120] F. Beck,et al. Dopaminergic modulation of corticosteroid responses to angiotensin II in man. , 1983, Clinical and experimental hypertension. Part A, Theory and practice.
[121] F. Halberg,et al. Chronobiologic assessment of human blood pressure variation in health and disease , 1984 .
[122] M. Cantin,et al. Specific receptor-mediated inhibition by synthetic atrial natriuretic factor of hormone-stimulated steroidogenesis in cultured bovine adrenal cells. , 1984, Endocrinology.
[123] B. Brenner,et al. Physiologic regulation of atrial natriuretic peptide receptors in rat renal glomeruli. , 1985, The Journal of clinical investigation.
[124] K. Kangawa,et al. α‐HUMAN ATRIAL NATRIURETIC POLYPEPTIDE REDUCES THE PLASMA ARGININE VASOPRESSIN CONCENTRATION IN HUMAN SUBJECTS , 1986, Clinical endocrinology.
[125] T. Tulassay,et al. Atrial natriuretic peptide and other vasoactive hormones in nephrotic syndrome. , 1987, Kidney international.
[126] F Halberg,et al. Cardiovascular reference data base for recognizing circadian mesor- and amplitude-hypertension in apparently healthy men. , 1984, Chronobiologia.
[127] K. Catt,et al. Hormonal regulation of peptide receptors and target cell responses , 1979, Nature.
[128] H. Yoshimi,et al. Specific receptors for atrial natriuretic factor (ANF) in cultured vascular smooth muscle cells of rat aorta. , 1984, Biochemical and biophysical research communications.
[129] C. Gomez-Sanchez,et al. Aldosterone suppression with dopamine infusion in low-renin hypertension. , 1983, The Journal of clinical investigation.
[130] I. Tikkanen,et al. PLASMA ATRIAL NATRIURETIC PEPTIDE IN CARDIAC DISEASE AND DURING INFUSION IN HEALTHY VOLUNTEERS , 1985, The Lancet.
[131] O. Carretero,et al. Effect of glandular kallikrein on renin release in isolated rat glomeruli. , 1985, Hypertension.
[132] J. Onrot,et al. Sodium Loading and Posture Modulate Human Atrial Natriuretic Factor Plasma Levels , 1986, Hypertension.
[133] T. Inoue,et al. Plasma levels of atrial natriuretic peptide in patients with chronic renal failure. , 1986, The Journal of clinical endocrinology and metabolism.
[134] P. Needleman,et al. Atriopeptin: a cardiac hormone intimately involved in fluid, electrolyte, and blood-pressure homeostasis. , 1986, The New England journal of medicine.
[135] F. Veglio,et al. Circadian rhythm of the angiotensin converting enzyme (ACE) activity in serum of healthy adult subjects. , 1987, Chronobiologia.
[136] H. Gavras,et al. Blood Pressure Response to Central and /or Peripheral Inhibition of Phenylethanolamine N‐Methyltransferase in Normotensive and Hypertensive Rats , 1981, Circulation research.
[137] A. Shore,et al. ATRIAL NATRIURETIC PEPTIDE LEVELS IN TREATED CONGESTIVE HEART FAILURE , 1986, The Lancet.
[138] T. Tunny,et al. PLASMA ATRIAL NATRIURETIC PEPTIDE IN PRIMARY ALDOSTERONISM (BEFORE AND AFTER TREATMENT) AND IN BARTTER'S AND GORDON'S SYNDROMES , 1986, The Lancet.
[139] E. Gomez-Sanchez. Intracerebroventricular infusion of aldosterone induces hypertension in rats. , 1986, Endocrinology.
[140] Y. Wakiya,et al. Relationship between plasma atrial natriuretic peptide levels and atrial pressure in man. , 1986, The Journal of clinical endocrinology and metabolism.
[141] P. Weidmann,et al. Depressor effects and release of atrial natriuretic peptide during norepinephrine or angiotensin II infusion in man. , 1986, Journal of Clinical Endocrinology and Metabolism.
[142] K. Berecek,et al. Whole Body Vascular Reactivity during the Development of Deoxycorticosterone Acetate Hypertension in the Pig , 1978, Circulation research.
[143] T. Inagami,et al. Synthetic rat atrial natriuretic factor inhibits in vitro and in vivo renin secretion in rats. , 1985, Endocrinology.
[144] P. Cugini,et al. Rhythm characteristics of plasma renin, aldosterone and Cortisol in five subtypes of mesor-hypertension , 1980, Journal of endocrinological investigation.
[145] A. Butkus,et al. THE AFFINITY OF 17α‐HYDROXYPROGESTERONE AND 17α, 20α‐DIHYDROXYPROGESTERONE FOR CLASSICAL MINERALOCORTICOID OR GLUCOCORTICOID RECEPTORS , 1982 .
[146] R. Cohn,et al. Alternate-day prednisone therapy after renal transplantation. , 1970, Lancet.
[147] H. Parving,et al. Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. , 1986, British medical journal.
[148] W. Forssmann,et al. Cardiac hormones. I. Review on the morphology, biochemistry, and molecular biology of the endocrine heart , 1986, European journal of clinical investigation.
[149] V. Fang,et al. A serotonergic mechanism of the prolactin-stimulating action of metoclopramide. , 1981, Endocrinology.
[150] A. D. Bold,et al. Atrial natriuretic factor: a hormone produced by the heart. , 1985, Science.
[151] K. Kangawa,et al. High plasma concentrations of human atrial natriuretic polypeptide in aged men. , 1987, The Journal of clinical endocrinology and metabolism.
[152] J. Sowers,et al. Effect of prostaglandin inhibition on the prolactin, renin, and aldosterone responses to dopamine antagonism. , 1982, Metabolism: clinical and experimental.
[153] M. Cantin,et al. Gluco- and mineralocorticoids may regulate the natriuretic effect and the synthesis and release of atrial natriuretic factor by the rat atria in vivo. , 1985, Biochemical and biophysical research communications.
[154] D. Streeten,et al. Use of an angiotensin II antagonist (saralasin) in the recognition of "angiotensinogenic" hypertension;. , 1975, The New England journal of medicine.
[155] A. Veress,et al. Cellular mechanism of release of atrial natriuretic factor. , 1984, Biochemical and biophysical research communications.
[156] D. Duval,et al. Cardiac glucocorticoid receptors: the binding of tritiated dexamethasone in rat and dog heart. , 1973, Endocrinology.
[157] A. Richards,et al. Effects of alpha-human atrial natriuretic peptide in essential hypertension. , 1985, Hypertension.
[158] G. Cornelissen,et al. Instrumentation for Human Blood Pressure Rhythm Assessment by Self-Measurement , 1987 .
[159] G. Williams,et al. Metoclopramide inhibits aldosterone biosynthesis in vitro. , 1982, Endocrinology.
[160] A. J. Bold. Heart atria granularity effects of changes in water-electrolyte balance. , 1979 .
[161] P. Weidmann,et al. Plasma arginine-vasopressin levels during infusion of synthetic atrial natriuretic peptide on different sodium intakes in man. , 1986, Journal of hypertension.
[162] R. Buñag. Circulatory Effects of Angiotensin , 1974 .
[163] C. Simon,et al. Nocturnal fluctuations of plasma atrial natriuretic peptide in normotensive and hypertensive men. , 1988, Life sciences.
[164] J. Laragh,et al. Prorenin and other large molecular weight forms of renin. , 1980, Endocrine reviews.
[165] P. Weidmann,et al. Increase in Circulating Insulin Induced by Atrial Natriuretic Peptide in Normal Humans , 1986, Journal of cardiovascular pharmacology.
[166] M. Cantin,et al. Synthetic Atrial Natriuretic Factor Induces Release (Possibly Receptor-Mediated) of Vasopressin from Rat Posterior Pituitary , 1985, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[167] G. Cornelissen,et al. Circadian characteristics of urinary melatonin from clinically healthy young women at different civilization disease risks. , 2009, Acta medica Scandinavica.
[168] D. Jacobowitz,et al. The nyctohemeral rhythm of plasma prolactin: effects of ganglionectomy, pinealectomy, constant light, constant darkness or 6-OH-dopamine administration. , 1975, Endocrinology.
[169] D. Ganten,et al. Atrial natriuretic factor—a circulating hormone stimulated by volume loading , 1985, Nature.
[170] M. Furuya,et al. Localization of binding sites for alpha-rat atrial natriuretic polypeptide in rat kidney. , 1986, The American journal of physiology.
[171] R. Carey,et al. Dopaminergic suppression of angiotensin II-induced aldosterone secretion in man: differential responses during sodium loading and depletion. , 1984, Metabolism: clinical and experimental.
[172] C. Simon,et al. Night-day differences in the ultradian rhythmicity of plasma renin activity. , 1987, Life sciences.
[173] H. Kunita,et al. The effects of dietary sodium on the diurnal activity of the renin-angiotensin-aldosterone system and the excretion of urinary electrolytes. , 1976, The Journal of clinical endocrinology and metabolism.
[174] M. Currie,et al. Evidence for α-1 adrenergic receptor regulation of atriopeptin release from the isolated rat heart , 1986 .
[175] N. Hollenberg,et al. Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensives. , 1985, The Journal of clinical investigation.
[176] W. Samson,et al. Atrial natriuretic factor inhibits dehydration- and angiotensin II-induced water intake in the conscious, unrestrained rat. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[177] K. Kangawa,et al. Inhibition of aldosterone production by alpha-human atrial natriuretic polypeptide is associated with an increase in cGMP production. , 1985, Biochemical and biophysical research communications.
[178] B. Brenner,et al. Atrial peptides inhibit oxygen consumption in kidney medullary collecting duct cells. , 1986, The American journal of physiology.
[179] A. Ganguly,et al. Metoclopramide Fails to Stimulate Aldosterone Secretion and Inhibits Serotonin-Mediated Aldosterone Secretion in the Rat , 1986, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[180] L. Krakoff,et al. Hormonal Control of Plasma Renin Substrate (Angiotensinogen) , 1977, Circulation research.
[181] J. Winnacker,et al. Low renin, "normal" aldosterone and hypertension: circadian rhythm of renin, aldosterone, cortisol and growth hormone. , 1974, The Journal of clinical endocrinology and metabolism.
[182] M. Schaller,et al. Dopaminergic Control of Aldosterone Secretion in Hypertensive Patients Chronically Treated with an Angiotensin Converting Enzyme Inhibitor , 1986, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[183] C. Edwards,et al. INHIBITION OF THE PLASMA-ALDOSTERONE RESPONSE TO FRUSEMIDE BY BROMOCRIPTINE , 1975, The Lancet.
[184] T. Saruta,et al. EFFECT OF METOCLOPRAMIDE ON THE SECRETION OF ALDOSTERONE AND OTHER ADRENOCORTICAL STEROIDS , 1983, Clinical endocrinology.
[185] D. Straughan,et al. Influence of 5‐hydroxytryptamine uptake on the apparent 5‐hydroxytryptamine antagonist potency of metoclopramide in the rat isolated superior cervical ganglion , 1987, British journal of pharmacology.
[186] M. Cantin,et al. Mechanisms of release of atrial natriuretic factor. II. Effect of chronic administration of α- and β-adrenergic and cholinergic agonists on plasma and atrial ANF in the rat , 1986 .
[187] J. Baxter,et al. Atrial natriuretic peptide mRNA is regulated by glucocorticoids in vivo. , 1986, Biochemical and biophysical research communications.
[188] R. Gordon,et al. Influence of sodium balance on ACTH/adrenal corticosteroid dose-response curves in the dog. , 1980, The American journal of physiology.
[189] D. Denton,et al. Dopaminergic modulation of aldosterone secretion? , 1981, The Journal of endocrinology.
[190] A. Shore,et al. RAISED CIRCULATING LEVELS OF ATRIAL NATRIURETIC PEPTIDES IN ESSENTIAL HYPERTENSION , 1986, The Lancet.
[191] R. Carey,et al. Dopamine modulates sodium-dependent aldosterone responses to angiotensin II in humans. , 1984, Hypertension.
[192] E. Haus,et al. Rhythm-adjusted age effects in a concomitant study of twelve hormones in blood plasma of women. , 1980, Journal of gerontology.
[193] R. Re. Cellular biology of the renin-angiotensin systems. , 1984, Archives of internal medicine.
[194] J. Habener,et al. Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. , 1986, The Journal of clinical investigation.
[195] J. Connell,et al. Dexamethasone-suppressible hyperaldosteronism. Adrenal transition cell hyperplasia? , 1986, Hypertension.
[196] W. Samson. Atrial natriuretic factor inhibits dehydration and hemorrhage-induced vasopressin release. , 1985, Neuroendocrinology.
[197] M. Currie,et al. Purification and sequence analysis of bioactive atrial peptides (atriopeptins). , 1984, Science.
[198] R. Lorenz,et al. Dopamine reduces aldosterone and 18-hydroxycorticosterone response to angiotensin II in patients with essential low-renin hypertension and idiopathic hyperaldosteronism. , 1985, Clinical science.
[199] G. Cornelissen,et al. The Chronobiologic Pilot Study with Special Reference to Cancer Research is Chronobiology or, rather, its Neglect Wasteful? , 1989 .
[200] R. Good,et al. Some Aspects of the Cardiovascular and Renal Circadian Systems , 1966, Circulation.
[201] B. E. Watkins,et al. Circadian Changes in Plasma Renin Activity and Plasma Aldosterone Concentrationin Two‐Kidney Hypertensive Rats , 1979, Hypertension.
[202] T. Inagami,et al. Immunohistological evidence for renin in human endocrine tissues. , 1985, The Journal of clinical endocrinology and metabolism.
[203] T. Goodfriend,et al. Inhibition of aldosterone synthesis by atrial natriuretic factor. , 1986, Federation proceedings.
[204] J. Grünfeld,et al. Effects of antiglucocorticoids on glucocorticoid hypertension in the rat. , 1985, Hypertension.
[205] H. Wernze,et al. Atrial natriuretic peptide in hepatic cirrhosis: relation to stage of disease, sympathoadrenal system and renin-aldosterone axis. , 1986, Klinische Wochenschrift.
[206] J. Reid,et al. Central and Peripheral Adrenergic Mechanisms in the Development of Deoxycorticosterone‐Saline Hypertension in Rats , 1975, Circulation research.
[207] J. Conn. Hypertension, the potassium ion and impaired carbohydrate tolerance. , 1965, The New England journal of medicine.
[208] S. Atlas. Atrial natriuretic factor: a new hormone of cardiac origin. , 1986, Recent progress in hormone research.
[209] J. Sowers,et al. Dopaminergic modulation of aldosterone secretion in man is unaffected by glucocorticoids and angiotensin blockade. , 1981, The Journal of clinical endocrinology and metabolism.
[210] F. Katz,et al. Diurnal variation of plasma aldosterone, cortisol and renin activity in supine man. , 1975, The Journal of clinical endocrinology and metabolism.
[211] G. Norbiato,et al. Metoclopramide increases vasopressin secretion. , 1986, The Journal of clinical endocrinology and metabolism.
[212] K. Kangawa,et al. Purification and complete amino acid sequence of α-human atrial natriuretic polypeptide (α-hANP) , 1984 .
[213] I. Miyamori,et al. Human atrial natriuretic polypeptide during escape from mineralocorticoid excess in man. , 1987, Clinical science.